The altered response to GCR has been associated with the pathogenesis of several diseases, such as metabolic syndrome [5], cardiovascular disease [6], rheumatoid arthritis [7], depression [8], and sporadic breast cancer among Caucasian women [9]. The gene discussed is NR3C1; the disease is metabolic syndrome.